Scrip Regulatory Affairs
ICH panel adopts revised safety guideline on genotoxicity testing of medicines
16 November 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- ICH to clarify E3 guideline on clinical study reports and alignment with CTD
- ICH outlines quality requirements for developing and manufacturing drug substances
- Calls for delay of EU medtech labelling decision as concerns continue
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
